Toshio Matsuoka < Toshio Tanaka < Toshiro Fukui

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Toshio Tanaka

Number of relevant bibliographic references: 43.
[0-20] [0 - 20][0 - 43][20-40]

Ident.	Authors (with country if any)	Title
001326 (2018)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]	Interleukin (IL-6) Immunotherapy.
001359 (2018)	Atsuhiko Iuchi [Japon] ; Hiroshi Harada [Japon] ; Toshio Tanaka [Japon]	IL-6 blockade for myocardial infarction.
001625 (2017)	Masashi Narazaki [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]	The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
001B49 (2016)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]	Immunotherapeutic implications of IL-6 blockade for cytokine storm.
001E72 (2015)	Sujin Kang [Japon] ; Toshio Tanaka [Japon] ; Tadamitsu Kishimoto [Japon]	Therapeutic uses of anti-interleukin-6 receptor antibody.
001F01 (2015)	Atsushi Ogata [Japon] ; Takayoshi Morita ; Yuji Yoshida ; Toshio Tanaka	Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis.
002007 (2015)	Toshio Tanaka	IL-6 blockade therapy for inflammatory diseases: current perspectives and future directions.
002026 (2015)	Yoshihito Shima [Japon] ; Naoki Hosen ; Toru Hirano ; Junsuke Arimitsu ; Sumiyuki Nishida ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Toshio Tanaka ; Tadamitsu Kishimoto ; Atsushi Kumanogoh	Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
002319 (2014)	Toshio Tanaka [Japon] ; Tadamitsu Kishimoto	The biology and medical implications of interleukin-6.
002380 (2014)	Atsushi Ogata [Japon] ; Kazuhide Tanimura ; Toyohiko Sugimoto ; Hiroshi Inoue ; Yukitomo Urata ; Tsukasa Matsubara ; Masakazu Kondo ; Yukitaka Ueki ; Mitsuhiro Iwahashi ; Shigeto Tohma ; Shuji Ohta ; Yukihiko Saeki ; Toshio Tanaka	Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.
002393 (2014)	Toshio Tanaka [Japon] ; Yoshihiro Hishitani [Japon] ; Atsushi Ogata [Japon]	Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors.
002413 (2014)	Yuji Yoshida [Japon] ; Toshio Tanaka [Japon]	Interleukin 6 and rheumatoid arthritis.
002421 (2014)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon]	IL-6 in inflammation, immunity, and disease.
002522 (2014)	Toshio Tanaka [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Tadamitsu Kishimoto [Japon]	A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
002677 (2013)	Yoshikazu Nakaoka ; Kaori Higuchi ; Yoh Arita ; Michio Otsuki ; Kaori Yamamoto ; Takahiro Hashimoto-Kataoka ; Taku Yasui ; Kuniyasu Ikeoka ; Tomohito Ohtani ; Yasushi Sakata ; Yoshihito Shima ; Atsushi Kumanogoh ; Keiko Yamauchi-Takihara ; Toshio Tanaka ; Tadamitsu Kishimoto ; Issei Komuro	Tocilizumab for the treatment of patients with refractory Takayasu arteritis.
002809 (2013)	Toshio Tanaka [Japon]	Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?
003426 (2012)	Atsushi Ogata [Japon] ; Toshio Tanaka	Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.
003431 (2012)	Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto	Therapeutic targeting of the interleukin-6 receptor.
003442 (2012)	Toshio Tanaka [Japon] ; Tadamitsu Kishimoto	Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.
003460 (2012)	Atsushi Ogata [Japon] ; Toru Hirano ; Yoshihiro Hishitani ; Toshio Tanaka	Safety and efficacy of tocilizumab for the treatment of rheumatoid arthritis.
003471 (2012)	Atsushi Ogata [Japon] ; Noriko Umegaki ; Ichiro Katayama ; Atsushi Kumanogoh ; Toshio Tanaka	Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Toshio Tanaka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Toshio Tanaka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Toshio Tanaka
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021